In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
From larvae to laundry: Sasol introduces insect oil-based surfactant
In Houston, Sasol has introduced a surfactant made from oil obtained from black soldier fly larvae.
Trade named LIVINEX IO 7, the insect-based surfactant meets...
Fungi fix: Dutch designer Dierkx shows mycelium can convert waste plastic into protein bars
In the Netherlands, designer Odette Dierkx has envisioned a new concept for producing protein bars: dried mycelium that has been fed waste plastics.
Dubbed...
Green toilet clean: Henkel taps LyondellBasell for biobased toilet cleaner packaging
In Germany, cleaning products giant Henkel is using biobased plastic from Houston’s LyondellBasell in its toilet cleaner packaging.
The packaging will specifically use LyondellBasell’s...